시장보고서
상품코드
1804444

상처 봉합 기구 키트 시장 : 키트 유형, 구성요소, 재료, 용도, 최종사용자, 유통 채널별 - 세계 예측(2025-2030년)

Wound Suture Instrument Kit Market by Kit Type, Component, Material, Application, End-User, Distribution Channel - Global Forecast 2025-2030

발행일: | 리서치사: 360iResearch | 페이지 정보: 영문 199 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

상처 봉합 기구 키트 시장의 2024년 시장 규모는 26억 8,000만 달러로 평가되었으며, 2025년에는 28억 5,000만 달러, CAGR 6.71%로 성장하여 2030년에는 39억 5,000만 달러에 달할 것으로 예측됩니다.

주요 시장 통계
기준 연도 2024년 26억 8,000만 달러
추정 연도 2025년 28억 5,000만 달러
예측 연도 2030년 39억 5,000만 달러
CAGR(%) 6.71%

의료 환경의 변화, 수술 정밀도에 대한 요구의 증가, 기술 발전으로 최첨단 상처 봉합기구를 위한 무대가 마련되었습니다.

의료진이 수술에 있어 그 어느 때보다 높은 정확성, 안전성, 효율성을 추구하게 되면서 상처 봉합용 기구 키트 시장이 주목받고 있습니다. 세계 인구의 고령화와 상처 봉합이 필요한 만성질환의 증가로 인해 수술실, 외래 환자 센터, 동물병원에서 이 키트는 필수적인 존재가 되었습니다. 동시에 최소침습적 시술과 회복 시간 단축에 대한 환자들의 기대가 높아지면서 의료기기 제조업체들은 디자인을 개선하고 최첨단 소재를 도입해야 하는 상황에 직면해 있습니다.

차세대 소재, 디지털 연결성, 환자 중심적 접근으로 촉진되는 상처 봉합사 키트 분야의 큰 변화를 살펴봅니다.

재료 과학과 디지털 통합의 혁신은 상처 봉합사 키트의 설계, 제조 및 배포 방식의 근본적인 변화를 촉진하고 있습니다. 조직의 외상을 줄이고 기구의 수명을 향상시키기 위해 각 제조업체들은 첨단 폴리머와 특수 코팅을 점점 더 많이 사용하고 있습니다. 이러한 재료 취급의 획기적인 발전은 더 가볍고 인체공학적인 핸들링을 가능하게 하여 외과 의사의 손재주를 향상시키고 장시간의 시술에도 피로를 줄일 수 있습니다.

2025년 미국 관세 조치가 봉합사 공급망, 제조 비용, 수입 전략, 세계 무역 역학을 재구성하는 방법 분석

2025년 미국에서 발효될 것으로 예상되는 관세 조치는 전체 봉합사 키트 부문의 조달, 가격 책정 및 공급망 전략에 영향을 미칠 것으로 예상됩니다. 정확한 조정률은 부품 및 재료의 분류에 따라 다르지만, 종합적인 영향은 원자재와 완제품 모두에 대한 수입관세 인상으로 나타날 것으로 보입니다. 그 결과, 제조업체와 유통업체는 공급업체 네트워크를 재평가하고, 상륙 비용의 상승을 상쇄하기 위해 새로운 조건을 협상해야 할 것으로 보입니다.

키트 유형, 부품 카테고리, 재료, 응용 분야, 최종사용자 환경, 유통 채널에 걸친 세분화 인사이트 공개

시장을 더 깊이 이해하기 위해서는 여러 부문을 면밀히 조사해야 합니다. 키트 유형에 따라 일회용 일회용 키트와 재사용 가능한 봉합 키트는 비용 효율성, 무균성 보장, 환경 영향 측면에서 각각 명확한 가치 제안을 제공합니다. 한편, 구성요소 분석에 따르면, 메스나 수술용 가위와 같은 절단 도구는 집게나 바늘 홀더와 같은 고정 도구와 공존하며, 소독 패드와 멸균 거즈에서 드레이프와 핀셋, 바늘과 실을 정확하게 조작하도록 설계된 봉합 전용 도구에 이르기까지 다양한 지원 항목에 의해 보완됩니다. 다양한 지원 아이템으로 보완됩니다.

아메리카, 유럽, 중동 및 아프리카, 아시아태평양의 상처 봉합사 키트 시장을 이끄는 지역 역학 확인

상처 봉합 기구 키트의 경쟁 구도를 형성하는 데 있어 지역 역학이 매우 중요한 역할을 하고 있습니다. 아메리카에서는 수술 인프라에 대한 투자 확대와 최소침습적 시술에 대한 관심이 병원과 외래 진료 모두에서 견조한 수요를 창출하고 있습니다. 또한, 북미에는 대형 기기 제조업체와 유통업체가 존재하기 때문에 제품 혁신을 가속화할 수 있는 경쟁 환경이 조성되어 있습니다.

혁신과 전략적 파트너십을 통해 상처 봉합사 키트의 경쟁 구도를 형성하는 저명한 업계 플레이어를 소개합니다.

상처 봉합 기구 키트 분야의 업계 리더십은 기술 혁신, 품질 기준 유지, 임상적 요구에 대한 신속한 대응 능력에 의해 결정됩니다. 일부 주요 업체들은 연구개발에 대한 지속적인 투자를 통해 차별화를 꾀하고 있으며, 독자적인 코팅과 인체공학적 핸들 디자인을 도입하고 있습니다. 학술 및 임상 기관과의 전략적 제휴는 신소재 및 신기술 검증을 용이하게 하고, 고객의 신뢰를 높이며, 프리미엄 가격 전략을 뒷받침하고 있습니다.

상처 봉합 기구 키트 부문의 성장을 촉진하고, 경쟁 포지셔닝을 강화하며, 혁신을 가속화하기 위한 전략적 제안을 제시합니다.

새로운 기회를 활용하고 진화하는 과제를 극복하기 위해 기업은 단기적인 경영 효율성과 장기적인 혁신의 균형을 맞추는 전략적 이니셔티브에 우선순위를 두어야 합니다. 첫째, 모듈식 키트 아키텍처에 투자함으로써 대규모 재설계 비용을 들이지 않고도 다양한 임상 용도에 맞게 신속하게 커스터마이징할 수 있습니다. 핵심 구성요소의 인터페이스를 표준화함으로써 제조업체는 개발 주기를 단축하고 맞춤형 솔루션의 임상 출시 시간을 단축할 수 있습니다.

1차 전문가 인터뷰, 2차 데이터 검토, 신뢰할 수 있는 인사이트를 위한 엄격한 검증을 결합한 견고한 다중 방법 연구 프레임워크에 대해 자세히 알아보기

본 분석은 최고 수준의 정확성과 신뢰성을 보장하기 위해 고안된 엄격한 다방법론적 조사 프레임워크를 기반으로 합니다. 여러 지역의 고위 경영진, 조달 책임자, 임상 전문가들과의 심층 인터뷰를 통해 1차적인 인사이트를 얻었습니다. 이러한 대화를 통해 채용 촉진요인, 미충족 수요, 혁신의 궤적에 대한 직접적인 인사이트를 얻을 수 있었습니다.

진화하는 상처 봉합 키트 생태계를 자신 있게 탐색할 수 있도록 의사결정자에게 힘을 실어주는 주요 발견과 전략적 핵심 사항 요약

이 인사이트는 상처 봉합 기구 키트를 둘러싼 이해관계자들에게 매우 중요한 시기임을 강조하고 있습니다. 소재 혁신이 디지털 기능 및 무역 정책의 변화와 결합하면서 시장 진입 기업이 가치 제안을 재정의하고 외과적 우수성을 촉진할 수 있는 기회가 도래하고 있습니다. 세분화 분석은 집중 투자해야 할 핵심 영역을 강조하고, 지역 역학은 적응형 시장 진입 전략의 필요성을 강조합니다.

목차

제1장 서문

제2장 조사 방법

제3장 주요 요약

제4장 시장 개요

제5장 시장 역학

제6장 시장 인사이트

  • Porter's Five Forces 분석
  • PESTEL 분석

제7장 미국 관세의 누적 영향 2025

제8장 상처 봉합 기구 키트 시장 : 키트 유형별

  • 일회용 봉합 키트
  • 재사용 가능한 봉합 키트

제9장 상처 봉합 기구 키트 시장 : 구성요소별

  • 절삭 공구
    • 메스
    • 외과용 가위
  • 보유 툴
    • 겸자
    • 니들 홀더
  • 서포트 툴
    • 소독 패드
    • 드레이프
    • 멸균 거즈
    • 핀셋
  • 봉합 기구

제10장 상처 봉합 기구 키트 시장 : 소재별

  • 폴리머 코팅
  • 스테인리스강
  • 티타늄

제11장 상처 봉합 기구 키트 시장 : 용도별

  • 심혈관외과
  • 치과외과
  • 일반외과
  • 안과 수술
  • 정형외과
  • 성형외과/미용외과
  • 수의학적 용도

제12장 상처 봉합 기구 키트 시장 : 최종사용자별

  • 학술 조사실
  • 외래 수술 센터(ASC)
  • 병원과 진료소

제13장 상처 봉합 기구 키트 시장 : 유통 채널별

  • 오프라인
  • 온라인

제14장 아메리카의 상처 봉합 기구 키트 시장

  • 미국
  • 캐나다
  • 멕시코
  • 브라질
  • 아르헨티나

제15장 유럽, 중동 및 아프리카의 상처 봉합 기구 키트 시장

  • 영국
  • 독일
  • 프랑스
  • 러시아
  • 이탈리아
  • 스페인
  • 아랍에미리트
  • 사우디아라비아
  • 남아프리카공화국
  • 덴마크
  • 네덜란드
  • 카타르
  • 핀란드
  • 스웨덴
  • 나이지리아
  • 이집트
  • 튀르키예
  • 이스라엘
  • 노르웨이
  • 폴란드
  • 스위스

제16장 아시아태평양의 상처 봉합 기구 키트 시장

  • 중국
  • 인도
  • 일본
  • 호주
  • 한국
  • 인도네시아
  • 태국
  • 필리핀
  • 말레이시아
  • 싱가포르
  • 베트남
  • 대만

제17장 경쟁 구도

  • 시장 점유율 분석, 2024
  • FPNV 포지셔닝 매트릭스, 2024
  • 경쟁 분석
    • Arthrex, Inc.
    • B. Braun SE
    • Baxter International Inc.
    • Becton, Dickinson and Company
    • Cardinal Health, Inc.
    • ConMed Corporation
    • Cook Incorporated
    • Ethicon, Inc. by Johnson & Johnson
    • Geister Medizintechnik GmbH
    • Hu-Friedy Mfg. Co., LLC
    • KLS Martin Group
    • Medacta International SA
    • Medline Industries, Inc.
    • Medtronic plc
    • Merit Medical Systems, Inc.
    • Olympus Corporation
    • Richard Wolf GmbH
    • Smith & Nephew plc
    • Surgical Specialties Corporation
    • Teleflex Incorporated
    • Vygon SA
    • Zimmer Biomet Holdings, Inc.

제18장 리서치 AI

제19장 리서치 통계

제20장 리서치 컨택트

제21장 리서치 기사

제22장 부록

KSM 25.09.10

The Wound Suture Instrument Kit Market was valued at USD 2.68 billion in 2024 and is projected to grow to USD 2.85 billion in 2025, with a CAGR of 6.71%, reaching USD 3.95 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 2.68 billion
Estimated Year [2025] USD 2.85 billion
Forecast Year [2030] USD 3.95 billion
CAGR (%) 6.71%

Setting the Stage for Cutting-Edge Wound Suture Instrumentation with Evolving Healthcare Dynamics, Rising Surgical Precision Needs, and Technological Advances

The wound suture instrument kit market is coming into sharp focus as healthcare providers demand ever greater precision, safety, and efficiency in surgical procedures. Driven by an aging global population and the rising prevalence of chronic conditions requiring wound closure, these kits have become indispensable in operating rooms, outpatient centers, and veterinary facilities. At the same time, patient expectations are escalating for minimally invasive techniques and faster recovery times, prompting instrument makers to refine designs and incorporate cutting-edge materials.

Furthermore, the convergence of digital health technologies with traditional surgical tools is unlocking new possibilities for traceability and procedure validation. From embedded RFID tags for real-time inventory management to instrument tracking software that reduces the risk of retained foreign bodies, tomorrow's kits are as much about data as they are about physical performance. This shift is challenging manufacturers to rethink product portfolios and invest in integrated solutions that bridge the gap between analog toolsets and digital workflows.

Moreover, regulatory bodies across key regions are tightening standards for sterility, materials biocompatibility, and manufacturing quality. The landscape is becoming more complex, with harmonization efforts underway but local requirements still dictating design and testing protocols. Suppliers must now navigate a patchwork of certifications and audits to achieve global market entry. Consequently, cross-functional collaboration between R&D, regulatory affairs, and supply chain teams is more critical than ever to maintain compliance while accelerating time-to-market.

Exploring Major Shifts in the Wound Suture Instrument Kit Space Fueled by Next-Generation Materials, Digital Connectivity and Patient-Centric Approaches

Innovation in materials science and digital integration is driving fundamental shifts in how wound suture instrument kits are designed, manufactured, and deployed. Manufacturers are increasingly adopting advanced polymers and specialized coatings to reduce tissue trauma and improve instrument longevity. These material breakthroughs are enabling lighter, more ergonomic handles that enhance surgeon dexterity and reduce fatigue during lengthy procedures.

Meanwhile, connectivity is reshaping supply chain and clinical workflows alike. Smart labeling and integrated sensor technology are not only streamlining inventory management but also ensuring full traceability for every kit component. As a result, sterilization processes can be validated more rapidly, and usage analytics can inform predictive restocking models. This data-driven approach is fostering leaner logistics operations and minimizing the risk of stock shortages or instrument obsolescence.

Patient-centric innovation is another transformative force. Kits are now being tailored to specific surgical specialties, from cardiovascular and ophthalmic applications to veterinary use, reflecting a trend toward bespoke solutions. Beyond the physical toolset, some providers are introducing virtual reality training modules to enhance surgical proficiency and reduce onboarding times for new staff. Collectively, these shifts are redefining the role of the instrument kit from a static set of tools to a dynamic, digitally enabled platform that supports clinical excellence and operational agility.

Analyzing How the 2025 United States Tariff Measures Reshape Supply Chains, Manufacturing Costs, Import Strategies and Global Trade Dynamics for Suture Kits

Anticipated tariff measures taking effect in the United States in 2025 are set to influence sourcing, pricing, and supply chain strategies across the wound suture instrument kit segment. Although the precise percentage adjustments vary by component and material classification, the overarching impact will be felt in elevated import duties on both raw materials and finished instruments. In turn, manufacturers and distributors will be compelled to reassess their supplier networks and negotiate new terms to offset higher landed costs.

Consequently, some players may accelerate localization efforts, forging partnerships with domestic steel fabricators or polymer producers to reduce reliance on cross-border shipments. Such shifts could also spur greater interest in dual-sourcing strategies, where critical tool families are manufactured across multiple geographies to hedge against tariff volatility. Meanwhile, procurement teams will need to build greater flexibility into contracts, incorporating clauses that address duty fluctuations and enable prompt renegotiation.

Furthermore, trade policy uncertainty is likely to elevate the importance of scenario planning within executive decision-making. Organizations must develop agile frameworks that allow for rapid adjustments to manufacturing footprints, inventory buffers, and distribution schedules. In doing so, they will protect margins, preserve lead times for end users, and maintain resilience in the face of evolving global trade dynamics.

Unveiling Segmentation Insights Across Kit Types, Component Categories, Materials, Application Domains, End-User Environments and Distribution Channels

A nuanced understanding of the market requires close examination of multiple segmentation dimensions. Based on kit type, there is a clear delineation between single-use disposable assemblies and reusable suture kits, with each offering distinct value propositions in terms of cost efficiency, sterility assurance, and environmental impact. Meanwhile, component analysis reveals that cutting instruments such as scalpels and surgical scissors coexist with holding implements like forceps and needle holders, complemented by support items that range from antiseptic pads and sterile gauze to drapes and tweezers, as well as dedicated suturing tools designed for precise needle and thread manipulation.

Material composition constitutes another vital lens, as polymer-coated instruments gain traction for their reduced surface friction and enhanced corrosion resistance, while traditional stainless steel remains a mainstay for its reliability and ease of maintenance. An emerging niche of titanium-based tools addresses the demand for ultra-lightweight and MRI-compatible devices in specialized settings. On the application front, cardiovascular, dental, general surgery, ophthalmic, orthopedic, and plastic or cosmetic procedures each impose unique design specifications, while veterinary use presents its own set of anatomical and procedural challenges.

Further granularity emerges in end-user segmentation, where academic and research laboratories prioritize precision and repeatability, ambulatory surgical centers emphasize portability and quick turnaround, and hospitals or clinics focus on comprehensive kit assortments that support high procedure volumes. Finally, distribution channels bifurcate into offline and online sales, with digital platforms enabling direct-to-provider offerings that streamline procurement and physical channels continuing to serve traditional group purchasing organizations and dealer networks.

Examining Regional Dynamics Driving the Wound Suture Instrument Kit Market across the Americas, Europe Middle East Africa and Asia-Pacific Landscapes

Regional dynamics play a pivotal role in shaping the competitive landscape of wound suture instrument kits. In the Americas, escalating investments in surgical infrastructure and a focus on minimally invasive techniques are generating robust demand across both hospital and ambulatory care settings. Moreover, the presence of leading instrument manufacturers and distributors in North America has fostered a highly competitive environment that accelerates product innovation.

Moving to Europe, the Middle East and Africa, regulatory harmonization across the European Union contrasts with fragmented requirements in certain Middle Eastern and African nations. This creates both opportunities and complexities for manufacturers seeking market entry. Healthcare systems in Western Europe are increasingly adopting value-based procurement models that favor kits demonstrating clear evidence of clinical and operational benefit, while emerging economies in regions such as the Gulf Cooperation Council are witnessing rapid expansion of private hospital networks.

Across the Asia-Pacific region, investments in surgical training and capacity expansion are driving kit adoption in both metropolitan centers and tier-2 cities. Local governments are encouraging domestic manufacturing through incentives and free-trade zones, which in turn is attracting multinational OEMs to establish regional production hubs. At the same time, online distribution channels are gaining momentum, driven by improvements in e-commerce infrastructure and growing confidence among clinicians in virtual procurement models.

Profiling Prominent Industry Players Shaping the Competitive Landscape of Wound Suture Instrument Kits through Innovation and Strategic Partnerships

Industry leadership in the wound suture instrument kit segment is determined by the ability to innovate, maintain quality standards, and respond swiftly to clinical needs. Several key players have distinguished themselves through continuous investment in research and development, introducing proprietary coatings and ergonomic handle designs that differentiate their offerings. Strategic collaborations with academic and clinical institutions have facilitated the validation of new materials and techniques, reinforcing customer confidence and supporting premium pricing strategies.

Additionally, certain firms have pursued vertical integration, consolidating manufacturing of raw materials such as medical-grade polymers and specialized steel alloys to secure supply continuity and cost advantages. Others are forging alliances with technology firms to incorporate digital identifiers and sterilization tracking into their kits, enhancing traceability and compliance. Beyond product innovation, distribution partnerships with global healthcare distributors have expanded market reach, while targeted acquisitions and joint ventures have allowed select companies to penetrate high-growth regional markets and close capability gaps in specialized surgical categories.

Presenting Strategic Recommendations to Drive Growth, Enhance Competitive Positioning and Accelerate Innovation in the Wound Suture Instrument Kit Sector

To capitalize on emerging opportunities and navigate evolving challenges, companies should prioritize strategic initiatives that balance short-term operational efficiency with long-term innovation. First, investing in modular kit architectures can enable rapid customization for diverse clinical applications without extensive redesign costs. By standardizing core component interfaces, manufacturers can reduce development cycles and accelerate time-to-clinic for tailored solutions.

Second, strengthening relationships with key opinion leaders through collaborative research programs will bolster credibility and yield early insights into procedural trends. Engaging surgeons and procurement specialists in co-creation forums fosters loyalty and informs product roadmaps. Moreover, embedding connectivity features such as RFID tags or QR codes will enhance supply chain transparency and position kits as integral elements of smart operating rooms.

Finally, enterprises should adopt agile pricing and sourcing models that anticipate regulatory or tariff shifts. Leveraging dual-sourcing arrangements and flexible contract terms will mitigate supply disruptions and preserve margin structures. Coupled with proactive scenario planning, these measures will equip leaders to pivot swiftly in response to policy changes, economic fluctuations, or unforeseen global events.

Detailing a Robust Multi-Method Research Framework Combining Primary Expert Interviews, Secondary Data Review and Rigorous Validation for Reliable Insights

This analysis is built upon a rigorous, multi-method research framework designed to ensure the highest level of accuracy and reliability. Primary insights were obtained through in-depth interviews with senior executives, procurement leaders, and clinical specialists across multiple regions. These conversations provided firsthand perspectives on adoption drivers, unmet needs, and innovation trajectories.

Complementing these findings, an extensive secondary data review was conducted, encompassing technical standards, regulatory filings, patent databases, and peer-reviewed publications. This repository was systematically validated through cross-reference with industry reports, corporate disclosures, and on-site audits of manufacturing facilities. The synthesis of primary and secondary inputs was further stress-tested using scenario modeling to assess the resilience of identified trends under varying market conditions.

Quality assurance protocols were applied throughout the research process, including triangulation of data sources, peer review by subject matter experts, and continuous alignment with evolving regulatory updates. This methodology ensures that the conclusions and recommendations presented are grounded in robust evidence and reflect the most current state of the wound suture instrument kit market.

Summarizing Key Findings and Strategic Imperatives to Empower Decision-Makers in Navigating the Evolving Wound Suture Instrument Kit Ecosystem with Confidence

The insights presented herein underscore a pivotal moment for stakeholders in the wound suture instrument kit landscape. As material innovations converge with digital capabilities and shifting trade policies, there is a window of opportunity for market participants to redefine value propositions and drive surgical excellence. The segmentation analysis highlights critical areas for targeted investment, while regional dynamics emphasize the need for adaptive market entry strategies.

Collaboration across the value chain-from raw material suppliers and instrument manufacturers to healthcare providers and technology partners-will be essential to unlock next-generation solutions. By embracing agile development processes, fostering stakeholder engagement, and implementing resilient sourcing frameworks, organizations can secure a leadership position. In doing so, they will not only meet the demands of today's clinical environment but also anticipate the procedural requirements of tomorrow.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Sizing & Forecasting

5. Market Dynamics

  • 5.1. Integration of smart sensor technology in surgical suturing instruments for real-time feedback on tissue tension
  • 5.2. Increasing adoption of bioresorbable suture materials in instrument kits to reduce postoperative complications
  • 5.3. Surge in research on nanofiber suture guides integrated into instrument kits to improve tissue regeneration outcomes
  • 5.4. Incorporation of digital tracking and barcoding in suture kits for inventory management and regulatory traceability
  • 5.5. Growing emphasis on single-use disposable suture instrument trays to enhance sterilization compliance in outpatient settings
  • 5.6. Utilization of antimicrobial coatings on needle holders and forceps to prevent surgical site infections in hospitals
  • 5.7. Rising demand for minimally invasive specialized suture kits tailored for robotic-assisted surgical platforms
  • 5.8. Development of ergonomic instrument handles to minimize surgeon hand fatigue during prolonged suturing procedures

6. Market Insights

  • 6.1. Porter's Five Forces Analysis
  • 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Wound Suture Instrument Kit Market, by Kit Type

  • 8.1. Introduction
  • 8.2. Disposable Suture Kit
  • 8.3. Reusable Suture Kit

9. Wound Suture Instrument Kit Market, by Component

  • 9.1. Introduction
  • 9.2. Cutting Tools
    • 9.2.1. Scalpels
    • 9.2.2. Surgical Scissors
  • 9.3. Holding Tools
    • 9.3.1. Forceps
    • 9.3.2. Needle Holders
  • 9.4. Support Tools
    • 9.4.1. Antiseptic Pads
    • 9.4.2. Drapes
    • 9.4.3. Sterile Gauze
    • 9.4.4. Tweezers
  • 9.5. Suturing Tools

10. Wound Suture Instrument Kit Market, by Material

  • 10.1. Introduction
  • 10.2. Polymer Coated
  • 10.3. Stainless Steel
  • 10.4. Titanium

11. Wound Suture Instrument Kit Market, by Application

  • 11.1. Introduction
  • 11.2. Cardiovascular Surgery
  • 11.3. Dental Surgery
  • 11.4. General Surgery
  • 11.5. Ophthalmic Surgery
  • 11.6. Orthopedic Surgery
  • 11.7. Plastic/Cosmetic Surgery
  • 11.8. Veterinary Use

12. Wound Suture Instrument Kit Market, by End-User

  • 12.1. Introduction
  • 12.2. Academic/Research Labs
  • 12.3. Ambulatory Surgical Centers (ASCs)
  • 12.4. Hospitals & Clinics

13. Wound Suture Instrument Kit Market, by Distribution Channel

  • 13.1. Introduction
  • 13.2. Offline
  • 13.3. Online

14. Americas Wound Suture Instrument Kit Market

  • 14.1. Introduction
  • 14.2. United States
  • 14.3. Canada
  • 14.4. Mexico
  • 14.5. Brazil
  • 14.6. Argentina

15. Europe, Middle East & Africa Wound Suture Instrument Kit Market

  • 15.1. Introduction
  • 15.2. United Kingdom
  • 15.3. Germany
  • 15.4. France
  • 15.5. Russia
  • 15.6. Italy
  • 15.7. Spain
  • 15.8. United Arab Emirates
  • 15.9. Saudi Arabia
  • 15.10. South Africa
  • 15.11. Denmark
  • 15.12. Netherlands
  • 15.13. Qatar
  • 15.14. Finland
  • 15.15. Sweden
  • 15.16. Nigeria
  • 15.17. Egypt
  • 15.18. Turkey
  • 15.19. Israel
  • 15.20. Norway
  • 15.21. Poland
  • 15.22. Switzerland

16. Asia-Pacific Wound Suture Instrument Kit Market

  • 16.1. Introduction
  • 16.2. China
  • 16.3. India
  • 16.4. Japan
  • 16.5. Australia
  • 16.6. South Korea
  • 16.7. Indonesia
  • 16.8. Thailand
  • 16.9. Philippines
  • 16.10. Malaysia
  • 16.11. Singapore
  • 16.12. Vietnam
  • 16.13. Taiwan

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. Arthrex, Inc.
    • 17.3.2. B. Braun SE
    • 17.3.3. Baxter International Inc.
    • 17.3.4. Becton, Dickinson and Company
    • 17.3.5. Cardinal Health, Inc.
    • 17.3.6. ConMed Corporation
    • 17.3.7. Cook Incorporated
    • 17.3.8. Ethicon, Inc. by Johnson & Johnson
    • 17.3.9. Geister Medizintechnik GmbH
    • 17.3.10. Hu-Friedy Mfg. Co., LLC
    • 17.3.11. KLS Martin Group
    • 17.3.12. Medacta International SA
    • 17.3.13. Medline Industries, Inc.
    • 17.3.14. Medtronic plc
    • 17.3.15. Merit Medical Systems, Inc.
    • 17.3.16. Olympus Corporation
    • 17.3.17. Richard Wolf GmbH
    • 17.3.18. Smith & Nephew plc
    • 17.3.19. Surgical Specialties Corporation
    • 17.3.20. Teleflex Incorporated
    • 17.3.21. Vygon SA
    • 17.3.22. Zimmer Biomet Holdings, Inc.

18. ResearchAI

19. ResearchStatistics

20. ResearchContacts

21. ResearchArticles

22. Appendix

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제